Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Antagen Institute for Biomedical Research is a Boston-based biotechnology company specializing in the development of advanced tools and services for antibody research. The company is widely recognized for its proprietary rapid antibody isotyping kits, which allow researchers to identify monoclonal antibody classes and subclasses in minutes. Beyond reagents, Antagen provides comprehensive services in cell line development, particularly utilizing high-yield CHO-K1 expression systems for recombinant protein and antibody production. Their expertise spans from early-stage hybridoma development to the manufacturing of diagnostic components for infectious diseases and oncology. Antagen also offers custom services for antibody humanization and affinity maturation to support therapeutic development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Antagen Institute for Biomedical Research.